Evidence map›Paper›PMID 20405020›Full record

ArticlePloS one2010

A monoclonal antibody toolkit for C. elegans.

Gayla Hadwiger, Scott Dour, Swathi Arur, Paul Fox, Michael L Nonet

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Amino acid and protein specificity of protein fatty acylation inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Analysis of the C. elegans Germline Stem Cell Pool.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. ExCel: Super-Resolution Imaging of C. elegans with Expansion Microscopy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Article
  18. Article
  19. ENPL-1, theDevelopment (Cambridge, England) · 2020
    Article
  20. Phenotypic Screening inPharmaceuticals (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gayla HadwigerDepartment of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Scott Dour
Swathi Arur
Paul Fox
Michael L Nonet
Washington University in St. Louis · US

Funding

Stem cell proliferation / meiosis decision in C. elegansR01GM063310 · NIGMS · WASHINGTON UNIVERSITY · PI SCHEDL, TIM · 2001 to 2008
$3.2M
MPK -1 ERK SUBSTRATES AND THE CONTROL OF GERMLINE DEVELOPMENTR01GM085150 · NIGMS · WASHINGTON UNIVERSITY · PI SCHEDL, TIM · 2008 to 2011
$1.3M
Monoclonal Antibody Resources for C. elegansR24RR022234 · NCRR · WASHINGTON UNIVERSITY · PI NONET, MICHAEL L · 2005 to 2007
$892k
NCRR NIH HHS R24 RR022234NIGMS NIH HHS GM085150NIGMS NIH HHS R01 GM063310NIGMS NIH HHS R01 GM085150NIGMS NIH HHS R01 GM63310
6 · The paper itself

Abstract

backgroundAntibodies are critical tools in many avenues of biological research. Though antibodies can be produced in the research laboratory setting, most research labs working with vertebrates avail themselves of the wide array of commercially available reagents. By contrast, few such reagents are available for work with model organisms. METHODOLOGY/PRINCIPAL

findingsWe report the production of monoclonal antibodies directed against a wide range of proteins that label specific subcellular and cellular components, and macromolecular complexes. Antibodies were made to synaptobrevin (SNB-1), a component of synaptic vesicles; to Rim (UNC-10), a protein localized to synaptic active zones; to transforming acidic coiled-coil protein (TAC-1), a component of centrosomes; to CENP-C (HCP-4), which in worms labels the entire length of their holocentric chromosomes; to ORC2 (ORC-2), a subunit of the DNA origin replication complex; to the nucleolar phosphoprotein NOPP140 (DAO-5); to the nuclear envelope protein lamin (LMN-1); to EHD1 (RME-1) a marker for recycling endosomes; to caveolin (CAV-1), a marker for caveolae; to the cytochrome P450 (CYP-33E1), a resident of the endoplasmic reticulum; to beta-1,3-glucuronyltransferase (SQV-8) that labels the Golgi; to a chaperonin (HSP-60) targeted to mitochondria; to LAMP (LMP-1), a resident protein of lysosomes; to the alpha subunit of the 20S subcomplex (PAS-7) of the 26S proteasome; to dynamin (DYN-1) and to the alpha-subunit of the adaptor complex 2 (APA-2) as markers for sites of clathrin-mediated endocytosis; to the MAGUK, protein disks large (DLG-1) and cadherin (HMR-1), both of which label adherens junctions; to a cytoskeletal linker of the ezrin-radixin-moesin family (ERM-1), which localized to apical membranes; to an ERBIN family protein (LET-413) which localizes to the basolateral membrane of epithelial cells and to an adhesion molecule (SAX-7) which localizes to the plasma membrane at cell-cell contacts. In addition to working in whole mount immunocytochemistry, most of these antibodies work on western blots and thus should be of use for biochemical fractionation studies. CONCLUSIONS/SIGNIFICANCE: We have produced a set of monoclonal antibodies to subcellular components of the nematode C. elegans for the research community. These reagents are being made available through the Developmental Studies Hybridoma Bank (DSHB).

Indexed as

AnimalsAntibodies, MonoclonalCaenorhabditis elegans ProteinsImmunologic TestsIndicators and ReagentsProteomicsAntibodies, MonoclonalCaenorhabditis elegans ProteinsIndicators and Reagents

Identifiers

PMID20405020
PMCPMC2854156
OpenAlexW2015684768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.